PCI Biotech Holding Overview
- Year Founded
-
2000
- Status
-
Out of Business
- Employees
-
7
- Latest Deal Type
-
Out of Business
PCI Biotech Holding General Information
Description
PCI Biotech Holding ASA is a biopharmaceutical company focused on developing and commercializing cancer therapies using its photochemical internalization (PCI) technology platform. The PCI technology utilizes light to trigger the release of compounds from within cellular compartments. The company applies PCI to three different approaches for cancer treatment: fimaCHEM: Enhancing chemotherapeutic drugs for localized cancer treatment. fimaVACC: Inducing T-cell responses for therapeutic cancer vaccination. fimaNAc: Delivering nucleic acid therapeutics. The key product candidate is fimaporfin (Amphinex), a photosensitizer that can unlock intracellular compartments where active compounds are trapped. The company's sole operating segment is research and development.
Contact Information
Website
www.pcibiotech.noCorporate Office
- Ullernchauséen 64
- 0379 Oslo
- Norway
Corporate Office
- Ullernchauséen 64
- 0379 Oslo
- Norway
PCI Biotech Holding Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Out of Business | Completed | Out of Business | ||||
| 8. Grant | 27-Jan-2017 | Completed | Profitable | |||
| 7. PIPE | 20-Jan-2017 | Completed | Profitable | |||
| 6. PIPE | 10-Jun-2010 | Completed | Generating Revenue | |||
| 5. Grant | 23-Mar-2009 | Completed | Generating Revenue | |||
| 4. IPO | 18-Jun-2008 | Completed | Generating Revenue | |||
| 3. Grant | 17-Jan-2007 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2006 | $803K | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Startup |
PCI Biotech Holding Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PCI Biotech Holding Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PCI Biotech Holding ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
PCI Biotech Holding FAQs
-
When was PCI Biotech Holding founded?
PCI Biotech Holding was founded in 2000.
-
Where is PCI Biotech Holding headquartered?
PCI Biotech Holding is headquartered in Oslo, Norway.
-
What is the size of PCI Biotech Holding?
PCI Biotech Holding has 7 total employees.
-
What industry is PCI Biotech Holding in?
PCI Biotech Holding’s primary industry is Drug Delivery.
-
Is PCI Biotech Holding a private or public company?
PCI Biotech Holding is a Private company.
-
What is PCI Biotech Holding’s current revenue?
The current revenue for PCI Biotech Holding is .
-
How much funding has PCI Biotech Holding raised over time?
PCI Biotech Holding has raised $33.8M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
